BIAFW
bioAffinity Technologies, Inc.
Price Chart
Latest Quote
$0.14
-0.02 (-10.47%)
Current Price
| Previous Close | $0.16 |
| Open | $0.47 |
| Day High | $0.14 |
| Day Low | $0.14 |
| Volume | 997 |
Stock Information
| Total Debt | $1.38M |
| Cash Equivalents | $3.10M |
| Revenue | $5.66M |
| Net Income | $-15.88M |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Sales | $5.66M |
| Income | $-15.88M |
| Book/sh | $0.81 |
| Employees | 57 |
Financial Ratios
| Quick Ratio | 1.19 |
| Current Ratio | 1.36 |
| Debt/Eq | 37.76 |
Returns & Margins
| ROA | -107.12% |
| ROE | -622.65% |
| Gross Margin | 33.08% |
| Operating Margin | -267.62% |
| Profit Margin | -280.57% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 0.17 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| RSI | nan |
| ATR | nan |
| Shares Float | 4.42M |
| Volatility | -1.33 |
| Rel Volume | 20.00 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| YTD | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $nan | 997 |
| 2026-06-12 | $0.29 | 0 |
| 2026-06-11 | $0.29 | 0 |
| 2026-06-10 | $0.29 | 0 |
| 2026-06-09 | $0.29 | 0 |
| 2026-06-08 | $0.29 | 0 |
| 2026-06-05 | $0.29 | 0 |
| 2026-06-04 | $0.29 | 0 |
| 2026-06-03 | $0.29 | 0 |
| 2026-06-02 | $0.29 | 0 |
| 2026-06-01 | $0.29 | 0 |
| 2026-05-29 | $0.29 | 0 |
| 2026-05-28 | $0.29 | 0 |
| 2026-05-27 | $0.29 | 0 |
| 2026-05-26 | $0.29 | 0 |
| 2026-05-22 | $0.29 | 0 |
| 2026-05-21 | $0.29 | 0 |
| 2026-05-20 | $0.29 | 0 |
| 2026-05-19 | $0.29 | 0 |
| 2026-05-18 | $0.29 | 0 |
About bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
đ° Latest News
BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath Lung
Zacks âĸ 2026-05-14T14:27:00Z
bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?
Zacks âĸ 2026-04-16T13:55:00Z
BC-Most Active Stocks
Associated Press Finance âĸ 2026-03-23T14:30:19ZBIAF Stock Down Following Q2 Earnings Despite CyPath Lung Growth
Zacks âĸ 2025-08-21T18:58:00Z
The Zacks Analyst Blog Highlights Meta Platforms, ServiceNow, Booking, Vaso and bioAffinity Technologies
Zacks âĸ 2025-07-01T13:33:00Z
Top Research Reports for Meta Platforms, ServiceNow & Booking
Zacks âĸ 2025-06-30T20:41:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $4,226,799 | $5,983,475 | $1,740,884 | $467 |
| Cost Of Revenue | $4,226,799 | $5,983,475 | $1,740,884 | $467 |
| Total Revenue | $6,107,959 | $9,362,022 | $2,532,499 | $4,803 |
| Operating Revenue | $6,103,099 | $9,354,651 | $2,510,984 | $0 |
| Expenses | ||||
| Interest Expense | $44,372 | $92,475 | $37,125 | $2,532,640 |
| Total Expenses | $16,734,467 | $18,315,467 | $10,505,727 | $4,015,861 |
| Other Income Expense | $-4,272,217 | $129 | $-27,796 | $-1,654,664 |
| Other Non Operating Income Expenses | $-461,939 | $129 | $-27,796 | $-1,866,922 |
| Net Non Operating Interest Income Expense | $-20,987 | $-74,865 | $85,006 | $-2,485,932 |
| Interest Expense Non Operating | $44,372 | $92,475 | $37,125 | $2,532,640 |
| Operating Expense | $12,507,668 | $12,331,992 | $8,764,843 | $4,015,394 |
| General And Administrative Expense | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-14,909,754 | $-9,039,831 | $-7,937,011 | $-8,154,113 |
| Net Interest Income | $-20,987 | $-74,865 | $85,006 | $-2,485,932 |
| Interest Income | $23,385 | $17,610 | $122,131 | $46,708 |
| Normalized Income | $-11,099,476 | $-9,039,831 | $-7,937,011 | $-8,366,371 |
| Net Income From Continuing And Discontinued Operation | $-14,909,754 | $-9,039,831 | $-7,937,011 | $-8,154,113 |
| Total Operating Income As Reported | $-10,572,508 | $-8,953,445 | $-7,973,228 | $-4,011,058 |
| Net Income Common Stockholders | $-14,909,754 | $-9,039,831 | $-7,937,011 | $-8,154,113 |
| Net Income | $-14,909,754 | $-9,039,831 | $-7,937,011 | $-8,154,113 |
| Net Income Including Noncontrolling Interests | $-14,909,754 | $-9,039,831 | $-7,937,011 | $-8,154,113 |
| Net Income Continuous Operations | $-14,909,754 | $-9,039,831 | $-7,937,011 | $-8,154,113 |
| Pretax Income | $-14,865,712 | $-9,028,181 | $-7,916,018 | $-8,151,654 |
| Interest Income Non Operating | $23,385 | $17,610 | $122,131 | $46,708 |
| Operating Income | $-10,626,508 | $-8,953,445 | $-7,973,228 | $-4,011,058 |
| Depreciation Amortization Depletion Income Statement | $504,836 | $605,637 | $249,592 | $10,182 |
| Depreciation And Amortization In Income Statement | $504,836 | $605,637 | $249,592 | $10,182 |
| Gross Profit | $1,881,160 | $3,378,547 | $791,615 | $4,336 |
| Special Income Charges | - | - | $0 | $212,258 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-10,506,226 | $-8,330,069 | $-7,629,301 | $-5,821,090 |
| Total Unusual Items | $-3,810,278 | - | $0 | $212,258 |
| Total Unusual Items Excluding Goodwill | $-3,810,278 | - | $0 | $212,258 |
| Reconciled Depreciation | $504,836 | $605,637 | $249,592 | $10,182 |
| EBITDA (Bullshit earnings) | $-14,316,504 | $-8,330,069 | $-7,629,301 | $-5,608,832 |
| EBIT | $-14,821,340 | $-8,935,706 | $-7,878,893 | $-5,619,014 |
| Diluted NI Availto Com Stockholders | $-14,909,754 | $-9,039,831 | $-7,937,011 | $-8,154,113 |
| Tax Provision | $44,042 | $11,650 | $20,993 | $2,459 |
| Gain On Sale Of Security | $-3,810,278 | - | - | - |
| Research And Development | $2,089,103 | $1,782,882 | $1,724,597 | $1,524,170 |
| Selling General And Administration | $9,913,729 | $9,943,473 | $6,790,654 | $2,481,042 |
| Other Special Charges | - | - | - | $-212,258 |
| Other Gand A | - | - | - | - |
Fetched: 2026-06-12
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $5,156,364 | $422,411 | $2,617,297 | $11,043,443 |
| Total Assets | $10,960,772 | $6,513,667 | $8,221,552 | $12,182,125 |
| Total Non Current Assets | $3,395,564 | $3,818,569 | $4,248,807 | $220,438 |
| Other Non Current Assets | $12,815 | $19,676 | $16,060 | $6,000 |
| Goodwill And Other Intangible Assets | $2,121,292 | $2,179,625 | $2,237,958 | $0 |
| Other Intangible Assets | $716,806 | $775,139 | $833,472 | - |
| Current Assets | $7,565,208 | $2,695,098 | $3,972,745 | $11,961,687 |
| Other Current Assets | $291,966 | $174,631 | $149,162 | $191,821 |
| Prepaid Assets | $227,950 | $248,364 | $171,855 | $340,078 |
| Inventory | $53,548 | $27,608 | $18,484 | $5,540 |
| Receivables | $541,962 | $1,139,204 | $811,674 | $10,489 |
| Other Receivables | $26,295 | $27,874 | $29,553 | $10,489 |
| Accounts Receivable | $515,667 | $1,111,330 | $782,121 | $0 |
| Cash Cash Equivalents And Short Term Investments | $6,449,782 | $1,105,291 | $2,821,570 | $11,413,759 |
| Cash And Cash Equivalents | $6,449,782 | $1,105,291 | $2,821,570 | $11,413,759 |
| Non Current Deferred Assets | - | - | - | $0 |
| Debt | ||||
| Total Debt | $1,160,821 | $1,501,194 | $1,578,639 | $251,746 |
| Long Term Debt And Capital Lease Obligation | $776,950 | $806,726 | $1,118,468 | $0 |
| Long Term Debt | $41,313 | $20,180 | - | - |
| Current Debt And Capital Lease Obligation | $383,871 | $694,468 | $460,171 | $251,746 |
| Current Debt | $105,161 | $171,669 | - | $251,746 |
| Other Current Borrowings | $105,161 | $171,669 | - | $251,746 |
| Net Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,683,116 | $3,911,631 | $3,366,297 | $1,138,682 |
| Total Non Current Liabilities Net Minority Interest | $776,950 | $806,726 | $1,118,468 | $0 |
| Current Liabilities | $2,906,166 | $3,104,905 | $2,247,829 | $1,138,682 |
| Current Deferred Liabilities | $42,405 | $24,404 | $33,058 | $0 |
| Payables And Accrued Expenses | $1,170,152 | $1,306,194 | $897,563 | $546,256 |
| Payables | $761,901 | $987,311 | $604,789 | $345,042 |
| Accounts Payable | $761,901 | $987,311 | $604,789 | $345,042 |
| Interest Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $7,277,655 | $2,602,036 | $4,855,255 | $11,043,443 |
| Preferred Stock Equity | $1 | - | - | - |
| Total Equity Gross Minority Interest | $7,277,656 | $2,602,036 | $4,855,255 | $11,043,443 |
| Stockholders Equity | $7,277,656 | $2,602,036 | $4,855,255 | $11,043,443 |
| Retained Earnings | $-68,554,064 | $-53,644,310 | $-44,604,479 | $-36,667,468 |
| Preferred Securities Outside Stock Equity | - | - | - | $0 |
| Other | ||||
| Ordinary Shares Number | $4,498,675 | $519,222 | $313,153 | $279,377 |
| Share Issued | $4,498,675 | $519,222 | $313,153 | $279,377 |
| Tangible Book Value | $5,156,363 | $422,411 | $2,617,297 | $11,043,443 |
| Invested Capital | $7,424,129 | $2,793,885 | $4,855,255 | $11,295,189 |
| Working Capital | $4,659,042 | $-409,807 | $1,724,916 | $10,823,005 |
| Capital Lease Obligations | $1,014,347 | $1,309,345 | $1,578,639 | $0 |
| Total Capitalization | $7,318,969 | $2,622,216 | $4,855,255 | $11,043,443 |
| Additional Paid In Capital | $75,800,258 | $56,139,753 | $49,393,972 | $47,652,242 |
| Capital Stock | $31,462 | $106,593 | $65,762 | $58,669 |
| Common Stock | $31,461 | $106,593 | $65,762 | $58,669 |
| Preferred Stock | $1 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $735,637 | $786,546 | $1,118,468 | $0 |
| Current Deferred Revenue | $42,405 | $24,404 | $33,058 | $0 |
| Current Capital Lease Obligation | $278,710 | $522,799 | $460,171 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,309,738 | $1,079,839 | $857,037 | $340,680 |
| Current Accrued Expenses | $408,251 | $318,883 | $292,774 | $201,214 |
| Goodwill | $1,404,486 | $1,404,486 | $1,404,486 | $0 |
| Net PPE | $1,261,457 | $1,619,268 | $1,994,789 | $214,438 |
| Accumulated Depreciation | $-704,246 | $-536,251 | $-373,123 | $-269,180 |
| Gross PPE | $1,965,703 | $2,155,519 | $2,367,912 | $483,618 |
| Leases | $32,781 | $19,353 | $9,941 | $0 |
| Other Properties | $1,675,859 | $1,906,630 | $2,183,370 | $462,155 |
| Machinery Furniture Equipment | $257,063 | $229,536 | $174,601 | $21,463 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Shares Number | - | - | $0 | - |
| Buildings And Improvements | - | - | $1,536,156 | $0 |
Fetched: 2026-06-12
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-9,389,410 | $-7,343,878 | $-6,060,708 | $-4,290,832 |
| Operating Activities | ||||
| Operating Cash Flow | $-9,328,842 | $-7,264,795 | $-6,037,806 | $-4,070,845 |
| Cash Flow From Continuing Operating Activities | $-9,328,842 | $-7,264,795 | $-6,037,806 | $-4,070,845 |
| Operating Gains Losses | $3,810,278 | - | - | $-212,258 |
| Investing Activities | ||||
| Capital Expenditure | $-60,568 | $-79,083 | $-22,902 | $-219,987 |
| Investing Cash Flow | $-60,568 | $-79,083 | $-2,209,399 | $-219,987 |
| Cash Flow From Continuing Investing Activities | $-60,568 | $-79,083 | $-2,209,399 | $-219,987 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $12,061,534 | $5,612,783 | $0 | $6,027,414 |
| Financing Cash Flow | $14,733,901 | $5,627,599 | $-344,984 | $14,343,953 |
| Cash Flow From Continuing Financing Activities | $14,733,901 | $5,627,599 | $-344,984 | $14,343,953 |
| Net Other Financing Charges | $-1,771,939 | $-1,261,898 | - | $-55,836 |
| Net Preferred Stock Issuance | $990,000 | $0 | - | - |
| Preferred Stock Issuance | $990,000 | $0 | - | - |
| Net Common Stock Issuance | $11,071,534 | $5,612,783 | $0 | $6,027,414 |
| Common Stock Issuance | $11,071,534 | $5,612,783 | $0 | $6,027,414 |
| Other | ||||
| Repayment Of Debt | $-369,721 | $-361,181 | $-344,984 | $-694,983 |
| Interest Paid Supplemental Data | $23,385 | $17,610 | $37,125 | $2,459 |
| Income Tax Paid Supplemental Data | $44,042 | $11,650 | $20,993 | $30,637 |
| End Cash Position | $6,449,782 | $1,105,291 | $2,821,570 | $11,413,759 |
| Beginning Cash Position | $1,105,291 | $2,821,570 | $11,413,759 | $1,360,638 |
| Changes In Cash | $5,344,491 | $-1,716,279 | $-8,592,189 | $10,053,121 |
| Proceeds From Stock Option Exercised | $4,814,027 | $1,446,046 | $0 | $7,788,210 |
| Net Issuance Payments Of Debt | $-369,721 | $-169,332 | $-344,984 | $584,165 |
| Net Long Term Debt Issuance | $-369,721 | $-169,332 | $-344,984 | $285,165 |
| Long Term Debt Payments | $-369,721 | $-361,181 | $-344,984 | $-269,983 |
| Net PPE Purchase And Sale | $-60,568 | $-79,083 | $-22,902 | $-219,987 |
| Purchase Of PPE | $-60,568 | $-79,083 | $-22,902 | $-219,987 |
| Change In Working Capital | $594,324 | $179,718 | $900,790 | $114,203 |
| Change In Other Working Capital | $19,225 | $-9,466 | $40,455 | - |
| Change In Payables And Accrued Expense | $93,857 | $631,432 | $347,511 | $621,455 |
| Change In Accrued Expense | $319,267 | $248,911 | $362,012 | $506,820 |
| Change In Payable | $-225,410 | $382,521 | $-14,501 | $114,635 |
| Change In Account Payable | $-225,410 | $382,521 | $-14,501 | $114,635 |
| Change In Prepaid Assets | $-90,060 | $-105,594 | $214,402 | $-492,753 |
| Change In Inventory | $-25,940 | $-9,124 | $-12,944 | $-5,540 |
| Change In Receivables | $597,242 | $-327,530 | $311,366 | $-8,959 |
| Stock Based Compensation | $671,474 | $989,681 | $748,823 | $248,592 |
| Depreciation Amortization Depletion | $504,836 | $605,637 | $249,592 | $10,182 |
| Depreciation And Amortization | $504,836 | $605,637 | $249,592 | $10,182 |
| Gain Loss On Investment Securities | $3,810,278 | - | - | - |
| Net Income From Continuing Operations | $-14,909,754 | $-9,039,831 | $-7,937,011 | $-8,154,113 |
| Issuance Of Debt | - | $191,849 | $0 | $1,279,148 |
| Long Term Debt Issuance | - | $191,849 | $0 | $555,148 |
| Net Business Purchase And Sale | - | $0 | $-2,186,497 | $0 |
| Purchase Of Business | - | $0 | $-2,186,497 | $0 |
| Change In Interest Payable | - | $0 | $0 | $440,485 |
| Net Short Term Debt Issuance | - | - | $0 | $299,000 |
| Short Term Debt Payments | - | - | $0 | $-425,000 |
| Short Term Debt Issuance | - | - | $0 | $724,000 |
| Other Non Cash Items | - | - | - | $3,922,549 |
Fetched: 2026-06-12